Description
Mebella is a two-dose injectable vaccine. While the first dose has to be administered at nine months of age, the second shot has to be given at the age of 16-24 months.
The vaccine was rolled out after extensive human clinical trials that proved its safety and efficacy and is aimed at addressing the urgent need to control the deadly measles and rubella virus that claims the lives of over one lakh children globally every year, IIL said.